Tau as a Drug Target in Alzheimer’s Disease

ISSN： 0895-8696

Source： Journal of Molecular Neuroscience, Vol.19, Iss.3, 2002-12, pp. : 337-338

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The β-secretase, BACE: A prime drug target for Alzheimer’s disease

By Vassar Robert

Journal of Molecular Neuroscience, Vol. 17, Iss. 2, 2001-10 ,pp. : 157-170

Humana Press, Inc

Access to resources Recommend Favorite

Cdk5 as a Drug Target for the Treatment of Alzheimer’s Disease

By Lau Lit-Fui Seymour Patricia A. Sanner Mark A. Schachter Joel B.

Journal of Molecular Neuroscience, Vol. 19, Iss. 3, 2002-12 ,pp. : 267-274

Humana Press, Inc

Access to resources Recommend Favorite

Tau as a Therapeutic Target for Alzheimer's Disease

Current Alzheimer Research, Vol. 8, Iss. 6, 2011-09 ,pp. : 666-677

Bentham Science Publishers

Access to resources Recommend Favorite

Tau Therapeutics for Alzheimer’s Disease : The Promise and the Challenges

By Gold Michael

Journal of Molecular Neuroscience, Vol. 19, Iss. 3, 2002-12 ,pp. : 329-334

Humana Press, Inc

Access to resources Recommend Favorite

TAU Aggregation is a Therapeutic Target for Alzheimer's Disease

Current Alzheimer Research, Vol. 7, Iss. 8, 2010-12 ,pp. : 665-669

Bentham Science Publishers

Access to resources Recommend Favorite